Medifast (NYSE: MED) reported Q2 EPS of ($0.28), $0.15 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $76.4 million versus the consensus estimate of $74.7 million.

For earnings history and earnings-related data on Medifast (MED) click here.